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Covid-19: A new global threat for future
generations
Dear Editor,
SARS-CoV-2 is a single-stranded RNA virus that acts through angiotensin-converting
enzyme 2 (ACE2) as its main receptor. ACE2 expression has been revealed to be
distributed in many organs of the human testis such as Leydig and Sertoli cells.
Also, this virus can induce oxidative stress and increase free radicals in these cells.
This event facilitates sperm DNA fragmentation that leads to reducing sperm motility
and viability. As has been demonstrated, Leydig and Sertoli cells are responsible for
influencing testosterone production and spermatogenesis. Angiotensin 1-7 is produced
by ACE2 in the testicular tissues that activate through the Mas receptor and increase
sperm motility via Phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling
pathway. In COVID-19, the expression of ACE2 in human cells is reduced. So, the
Ang (1-7)/Mas/PI3K/AKT3 pathway is destroyed in the testis. This alteration in turn may
decrease spermatogenesis, sperm motility, and male fertility. Moreover, this virus has
been detected in the patients’ semen 36 days after recovery. SARS-CoV-2 induce
hyper-inflammatory syndrome by increasing inflammatory cytokines’ actions through the
ACE2 receptor. This event can produce pulmonary, distal alveoli, pulp, and irreversible
damages in other organs that can further cause the cell apoptosis and multi-organ
system failure (1-8). Therefore, due to the irreversible damage of SARS-CoV-2 to other
organs such as the lungs through a mechanism similar to the mechanism of action in
the testis and the long-term presence of that in the semen or male reproductive system,
it can be suggested that this virus can induce male reproductive disorders in patients
with COVID-19 in future. Hence, male infertility in patients with COVID-19 should be
considered as a serious problem in the future generation that will require extensive
clinical research to clarify its related problems and ways to treat them.
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